Research

AnHorn Medicines is a dynamic drug discovery company focused on the development of next-generation targeted protein degradation therapies. AnHorn’s AI-platform enables for the discovery of more drug-like, orally bioavailable protein degraders.   Role Summary: AnHorn Medicines is currently seeking a highly motivated and team-oriented candidate for the position, in the Department of Clinical. The successful […]

AnHorn Medicines is a novel drug discovery company focusing on protein degraders and small molecular inhibitors targeting cancer, neurodegeneration, and aging diseases. Our mission is to develop new class of drugs BIGPRO® under the foundation of Targeted Protein Degradation (TPD), to address a broad range of life-threatening and life-impairing diseases.   Position Summary We are

AnHorn Medicines is a novel drug discovery company focusing on protein degraders and small molecular inhibitors targeting cancer, neurodegeneration, and aging diseases. Our mission is to develop new class of drugs BIGPRO® under the foundation of Targeted Protein Degradation (TPD), to address a broad range of life-threatening and life-impairing diseases.   Position Summary We are